UNI-MB - logo
UMNIK - logo
 

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov UM. Za polni dostop se PRIJAVITE.

1
zadetkov: 2
1.
  • Addition of gemtuzumab ozog... Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
    Hills, Robert K, DPhil; Castaigne, Sylvie, Prof; Appelbaum, Frederick R, Prof ... The lancet oncology, 08/2014, Letnik: 15, Številka: 9
    Journal Article
    Recenzirano
    Odprti dostop

    Summary Background Gemtuzumab ozogamicin was the first example of antibody-directed chemotherapy in cancer, and was developed for acute myeloid leukaemia. However, randomised trials in which it was ...
Celotno besedilo

PDF
2.
  • Arsenic trioxide and all- t... Arsenic trioxide and all- trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
    Burnett, Alan K, Prof; Russell, Nigel H, Prof; Hills, Robert K, DPhil ... The lancet oncology, 10/2015, Letnik: 16, Številka: 13
    Journal Article
    Recenzirano

    Summary Background Acute promyelocytic leukaemia is a chemotherapy-sensitive subgroup of acute myeloid leukaemia characterised by the presence of the PML–RARA fusion transcript. The present standard ...
Celotno besedilo

Nalaganje filtrov